Evommune, Inc. (EVMN)
21.93
+0.71
(+3.35%)
USD |
NYSE |
Dec 04, 16:00
22.50
+0.57
(+2.60%)
Pre-Market: 05:36
Evommune Total Assets (Quarterly): 96.21M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BillionToOne, Inc. | 312.63M |
| Denali Therapeutics, Inc. | 1.056B |
| Quince Therapeutics, Inc. | 109.90M |
| Sonnet BioTherapeutics Holdings, Inc. | 2.055M |
| Omada Health, Inc. | 287.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 267.44M |
| Shareholders Equity (Quarterly) | -171.23M |
| Debt to Equity Ratio | -1.506 |
| Current Ratio | 9.403 |